Kindred Bio Stock Price, News & Analysis

KIN NASDAQ

Company Description

Kindred Bio (NASDAQ: KIN) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

KIN stock has gained 134.2% over the past year.

This page provides a comprehensive overview of KIN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+134.18%

Performance 1 year

$0.0

Market Cap

45.5M

Shares outstanding

Kindred Bio (KIN) stock. Over the past 12 months, the stock has gained 134.2%.

Latest News

View All

June 16, 2021

+45.58%

Elanco Announces Agreement to Acquire Kindred Biosciences

acquisition

June 16, 2021

+45.58%

Elanco Announces Agreement to Acquire Kindred Biosciences

acquisition

June 2, 2021

+15.99%

Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus

May 25, 2021

-4.79%

Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI

conferences

May 11, 2021

-2.93%

Kindred Biosciences Announces First Quarter 2021 Financial Results

earnings

May 3, 2021

+0.40%

Kindred Biosciences to Announce First Quarter 2021 Financial Results

earnings

Kindred Bio has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, conferences, earnings. View all KIN news →

SEC Filings

View All

No SEC filings available for KIN.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

KIN Company Profile & Sector Positioning

Kindred Bio (KIN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.